News | March 05, 2014

Esaote Launches Crystaline Ultrasound Technology at ECR 2014


March 5, 2014 — Esaote has launched CrystaLine, a significant evolution of its ultrasound technology that delivers new levels of accuracy, quality, versatility and value. Esaote will showcase the new technology at the 2014 annual meeting of the European Congress of Radiology in Vienna, March 6-10.

CrystaLine’s technical capabilities enable high-quality images to be captured at greater depth in the body. This significant improvement overcomes the challenges associated with larger and more technically difficult to scan patients.

CrystaLine incorporates specific hardware and software features that build on the advanced eHD ultrasound technology Esaote introduced last year. The reality of higher quality, clearer imaging at increased depth, now enables clinicians to confidently use ultrasound in borderline examinations and interventional ultrasound procedures. 

Carlos Faustmann, Esaote’s chief global marketing and domestic sales officer, said, “Ultrasound is highly valued for its safe, noninvasive nature, and continues to evolve and prove its value. One of the challenges has been capturing high-quality images in those technically difficult patients. CrystaLine changes that.”

Technical improvements provided by CrystaLine include combined pulse imaging technology, which effectively increases depth-of-field, improving the imaging of structures deeper in the body. Combined with the new XView+ speckle-noise reduction system, fully adjustable by the operator, it helps to produce an optimal personalized image.

Esaote systems with CrystaLine are also able to synchronize in real-time with therapeutic applications such as Echolaser to guide laser ablation and other procedures. “CrystaLine enables clinicians to synchronize with interventional systems such as medical lasers,” said Faustmann. “This feature plus the introduction of the 0 degrees biopsy-interventional dedicated probe, is an example of the huge potential for Esaote and ultrasound in direct therapeutic applications.”

CrystaLine is available across Esaote’s MyLabTwice, Seven and Alpha ultrasound systems.

For more information: www.esaote.com


Related Content

News | Ultrasound Imaging

Aug. 22, 2024 – AISAP has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for ...

Home August 27, 2024
Home
News | Ultrasound Imaging

April 3, 2024 — GE HealthCare announced the launch of Caption AI artificial intelligence (AI)-driven software for rapid ...

Home April 03, 2024
Home
News | Ultrasound Imaging

April 3, 2024 — - Eko Health, a pioneer in applying artificial intelligence (AI) for early detection of heart and lung ...

Home April 03, 2024
Home
News | Ultrasound Imaging

September 15, 2023 — Contrast enhanced ultrasound (CEUS) is underutilized in the United States, and reduced access to ...

Home September 15, 2023
Home
News | Ultrasound Imaging

August 3, 2023 — Butterfly Network, Inc. a digital health company transforming care through the power of portable ...

Home August 03, 2023
Home
News | Ultrasound Imaging

May 11, 2023 — Esaote, a leading manufacturers of medical diagnostic systems (specifically, ultrasound, dedicated MRI ...

Home May 11, 2023
Home
News | Ultrasound Imaging

April 24, 2023 — Butterfly Network, Inc., a digital health company transforming care through the power of handheld ...

Home April 24, 2023
Home
News | Ultrasound Imaging

January 30, 2023 — Heart disease is the leading cause of death worldwide. In the U.S., it is estimated that someone dies ...

Home January 30, 2023
Home
News | Ultrasound Imaging

December 8, 2022 — Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ...

Home December 08, 2022
Home
News | Ultrasound Imaging

August 10, 2022 — Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ...

Home August 10, 2022
Home
Subscribe Now